FDA import alert

Import Alert 57-11

DETENTION WITHOUT PHYSICAL EXAMINATION OF UNLICENSED IMMUNE GLOBULIN INTRAVENOUS (HUMAN)

2

Red-list entries

0

Green-list entries

1

Countries

2009-09-10

Last change seen

Official FDA source ↗Data refreshed 2026-07-11 UTC

What being on this list means

Firms on an import alert's Red List are subject to Detention Without Physical Examination (DWPE): FDA can detain their shipments at the border automatically, without sampling or inspecting them. The burden shifts to the importer to prove — typically with private laboratory analysis, shipment by shipment — that the goods are not violative. Removal from the list requires evidence that the underlying problem is resolved, usually including a track record of consecutive clean shipments and a petition to FDA. How removal works →

A Green List on a countrywide alert works the other way: it names the firms FDA has excluded from detention because they demonstrated compliance.

Red-list entries by country

CountryEntries
United Kingdom2

Firms on this red list

Showing 2 of 2 entries — search a specific firm on the free checker.

  • A.D. Allen Pharmaceutical Wholesaler

    09/10/2009

    United Kingdom · Immune Globulin Intravenous, Final Product; Ready For Use

  • B & S Durbin Ltd

    09/10/2009

    United Kingdom · Immune Globulin Intravenous, Final Product; Ready For Use

Does this alert touch your supply chain?

Put your suppliers on watch: we re-check this list (and every other import alert) daily against the official FDA source and email you the day a firm you depend on is added or removed.

Monitor my suppliers